    |
Summary (updated on 13 May 2004)
32 papers in refereed journals
9 book chapters
3 patents
Recent Representative Publications
|
| 1. |
Gallazzi F, Wang Y, Jia F, Shenoy N, Landon L, Hannink M, Lever SZ, Lewis MR. Synthesis of Radiometal-Labeled and Fluorescent Cell-Permeating Peptide-PNA Conjugates for Targeting the bcl-2 Proto-oncogene. Bioconjugate Chem. 14:1083-1095, 2003.
|
| 2. |
Zhu XF, Lever SZ. Analysis of meso-2,3-dimercaptosuccinic acid in human urine by capillary electrophoresis using direct injection. Anal. Bioanal. Chem. 377:666-669, 2003.
|
| 3. |
Lever SZ. The Evolution of Radiopharmaceuticals for Diagnosis and Therapy. J. Cell. Biochem. Suppl. 39:60-64, 2002 (invited).
|
| 4. |
Lewis MR, Jia F, Gallazzi F, Wang Y, Zhang J, Shenoy N, Lever SZ, Hannink M. Radiometal-labeled Peptide-PNA Conjugates for Targeting bcl-2 Expression: Preparation, Characterization, and in Vitro mRNA Binding. Bioconjugate Chem. 13:1176-1180, 2002.
|
| 5. |
Zhu XF, Lever SZ. Formation Kinetics and Stability Studies on the Lanthanide Complexes of 1,4,7,10-tetraazacyclododecane-N-N’,N’’,N’’’-tetraacetic acid by Capillary Electrophoresis. Electrophoresis, 23:1348-1356, 2002.
|
| 6. |
Lever SZ, Lydon JD, Cutler CS, Jurisson SS. “Radioactive Metals in Imaging and Therapy.” In Comprehensive Coordination Chemistry II. McCleverty JA and Meyer TJ (eds.) Vol. 9, Chapter 20, MD Ward, Volume Editor. Elsevier Science, Oxford, UK, 2003, pp 883-911, (invited).
|
| 7. |
Gallazzi F, Wang Y, Jia F, Shenoy N, Lever SZ, Lewis MR. “Preparation of Peptide-PNA Conjugates for Imaging and Therapy of Oncogene Expression.” In: Peptides 2002: Proceedings of the 27th European Peptide Symposium, Edizioni Ziino, Napoli IT, 2003, pp.948-949.
|
| 8. |
S. Z. Lever and T. L. Parsons
The Presence of Lead Decreases the Availability of meso-2,3-Dimercaptosuccinic Acid in the Monobromobimane Assay.
Chem Res Toxicol, 1999, 12, 1057-1065.
|
| 9. |
K. E. Baidoo, U. Scheffel, M. Stathis, P. Finley, Y. Zhan, S. Z. Lever and H. N. Wagner Jr.
High Affinity No Carrier Added Technetium-99m Labeled Chemotactic Peptides for Studies of Inflammation In Vivo
Bioconjugate Chem. 1998, 9, 208-217.
|
| 10. |
S. Z. Lever and U. Scheffel
Regional Distribution of 203PbCl2 in the Mouse after Intravenous Injection.
Neurotoxicology 1998, 19, 197-208.
|
| 11. |
C. -H. K..Kao, K. E. Baidoo and S. Z. Lever
Validation and Application of a Solid Phase Chemistry Method for Preparation of High Effective Specific Activity Technetium-99m Radiopharmaceuticals.
Nucl Med Biol. 1997, 24, 499-505.
|
|
Susan Z. Lever